|
Azilsartan Medoxomil
|
阿奇沙坦酯
|
863031-21-4
|
|
Nafamostat Mesylate
|
甲磺酸萘莫司他
|
82956-11-4
|
|
Tolvaptan
|
托伐普坦
|
150683-30-0
|
|
Sevelamer carbonate
|
碳酸司維拉姆
|
845273-93-0
|
|
Methyl Raloxifene
|
甲基雷洛昔芬
|
|
|
AT-MA
|
(Z)-2-(2-氨基噻唑-4-基)-2-叔丁氧羰甲氧亞氨基乙酸
|
74440-02-1
|
|
Ticagrelor impurity 1~4
|
Ticagrelor related substance替格瑞洛相關(guān)物質(zhì)
|
1643378-47-5
|
|
Ticagrelor Impurity 2
|
Ticagrelor
related substance
替格瑞洛相關(guān)物質(zhì)
|
|
|
Ticagrelor Impurity 4
|
Ticagrelor
related substance
替格瑞洛相關(guān)物質(zhì)
|
|
|
Sitagliptin racemate
|
Sitagliptin
related substance
西格列汀相關(guān)物質(zhì)
|
|
|
S-isomer
|
Sitagliptin
related substance
西格列汀相關(guān)物質(zhì)
|
|
|
Impurity H
|
Sitagliptin
related substance
西格列汀相關(guān)物質(zhì)
|
|
|
Silodocin intermediate (239463-85-5)
Optical isomer
|
Silodocin
related substance
西洛多辛相關(guān)物質(zhì)
|
|
|
m-Chloride isomer
|
Rebamipide
related substance
瑞巴派特相關(guān)物質(zhì)
|
|
|
Impurity A
|
Lesinurad
related substance
雷西納德 相關(guān)物質(zhì)
|
|
|
Diclofenac Epolamine Degradation Impurity 2
|
Diclofenac Epolamine
related substance
雙氯芬酸依波胺相關(guān)物質(zhì)
|
|
|
Pranoprofen impurity 2
|
Pranoprofen
related substance
普拉洛芬相關(guān)物質(zhì)
|
52549-19-6
|
|
BIBR1155
|
Dabigatran etexilate
related substance
達比加群脂相關(guān)物質(zhì)
|
1408238-37-8
|
|
CDBA513BS
|
Dabigatran etexilate
related substance
達比加群脂相關(guān)物質(zhì)
|
|
|
Imp-1
|
Elaglolix related substance
噁拉戈利相關(guān)物質(zhì)
|
|
|
Jaceosidin
|
Index substance for Artemisia extract
艾葉提取物活性成分
|
|
|
Oseltamivir impurity 4
|
Oseltamivir Phosphate
related substance
奧司他韋相關(guān)物質(zhì)
|
|
|
Montelukast Sodium
|
孟魯司特鈉
|
151767-02-1
|
|
Sertraline Hydrochloride
|
鹽酸舍曲林
|
79559-97-0
|
|
Dapagliflozin
|
達格列凈
|
461432-26-8
|
|
Empagliflozin
|
恩格列凈
|
864070-44-0
|
|
Trimebutine Maleate
|
曲美布汀馬來酸鹽
|
34140-59-5
|
|
Entecavir Hydrate
|
恩替卡韋
|
209216-23-9
|
|
Hydroxyzine
Hydrochloride
|
鹽酸羥嗪
|
2192-20-3
|
|
Mizolastine
|
咪唑斯汀
|
108612-45-9
|
|
Atorvastatin Calcium Anhydrous
|
阿托伐他汀鈣無水物
|
134523-03-8
|
|
Atorvastatin Calcium Trihydrate
|
阿托伐他汀鈣三水物
|
344423-98-9
|
|
Ezetimibe
|
依替米貝
|
163222-33-1
|
|
Rosuvastatin Calcium
|
瑞舒伐他汀鈣
|
147098-20-2
|
|
Amlodipine Besylate
|
苯磺酸氨氯地平
|
111470-99-6
|
|
Telmisartan
|
替米沙坦
|
144701-48-4
|
|
Valsartan
|
纈沙坦
|
137862-53-4
|
|
Oseltamivir Phosphate
|
磷酸奧司他韋
|
204255-11-8
|
|
Eribulin Mesylate
|
甲磺酸艾瑞布林
|
441045-17-6
|
|
Oxaliplatin
|
奧沙利鉑
|
61825-94-3
|
|
D-Dapoxetine Hydrochloride
|
鹽酸達泊西汀
|
129938-20-1
|
|
Tadalafil
|
他達那非
|
171596-29-5
|
|
Vardenafil HCl
|
瓦地拉非鹽酸鹽
|
224785-91-5
|
|
Docusate sodium with Sodium benzoate
|
85%多庫脂鈉+15%苯甲酸鈉復(fù)合物
|
577-11-7
|
|
Mycophenolate Mofetil
|
嗎替麥考酚酯
|
115007-34-6
|
|
Adenine
|
腺嘌呤
|
73-24-5
|
|
Dantrolene Na
|
丹曲林鈉
|
14663-23-1
|
|
Oxiracetam
|
奧拉西坦
|
62613-82-5
|
|
Varenicline Tartrate
|
酒石酸伐倫克林
|
375815-87-5
|
|
Mecobalamin
|
甲鈷胺
|
13422-55-4
|
|
Cyanocobalamin
|
氰鈷胺
|
68-19-9
|
|
Pyridoxine hydrochloride
|
鹽酸吡哆醇
|
58-56-0
|
|
Paricalcitol
|
帕立骨化醇
|
131918-61-1
|
|
Methyl-[E]-2-[3-(S)-[3-[2-(7-chloro-2-quinolinyl)ethenyl]-phenyl]-3-hydroxy-propyl]benzoate
|
2-[3-(S)-[3-[2-(7-氯-2-喹啉基)乙烯基]苯基]-3-羥基丙基]苯甲酸甲酯
|
142569-69-5
|
|
(S)-1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)ph-enyl)-3-(2-(1-hydroxy-1-methylethyl)-phenyl)propanol
|
(S)- 1-(3-(2-(7-氯-2-喹啉基)-乙烯基)苯基)-3-(2-(1-羥基-1-甲基乙基)苯基)-丙醇
|
142569-70-8
|
|
3-Trifluoro methyl-[1,2,4]triazole[4,3-a]piperazine hydrochloride
|
3-(三氟甲基)-5,6,7,8-四氫-[1,2,4]三唑并[4,3-a]吡嗪鹽酸鹽
|
762240-92-6
|
|
Boc-(R)-3-Amino-4-(2,4,5-trifluoro-phenyl)butanoic acid
|
Boc-(R)-3-氨基-4-(2,4,5-三氟苯基)丁酸; (3R)-N-叔丁氧羰基-3-氨基-4-(2,4,5-三氟苯基)丁酸
|
486460-00-8
|
|
L-1
|
(4R-cis)-6-[2-[2-(4-氟苯基)-5-(1-異丙基)-3-苯基-4-[(苯胺)羰基]-1H-吡咯-1-基]乙基]-2,2-二甲基-1,3-二氧六環(huán)-4-乙酸叔丁酯
|
125971-95-1
|
|
Atorvastatin tert-butyl ester
|
阿托伐他汀叔丁酯
|
134395-00-9
|
|
(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxo-
penyl]-4-phenyl-2-
oxazolidinone
|
(4S)-3-[5-(4-氟苯基)-1,5-二氧代戊基]-4-苯基-2-惡唑烷酮
|
189028-93-1
|
|
3-[5-(4-fluoro-
phenyl)-5-hydroxy-
pentanoyl]-5-phenyl-
oxazolidin-2-one
|
(4S)-3-[(5S)-5-(4-氟苯基)-5-羥基戊?；鵠-4-苯基-1,3-氧氮雜環(huán)戊烷-2-酮
|
189028-95-3
|
|
Z-9
|
4-(4-氟苯基)-6-異丙基-2-(N-甲基-N-甲磺?；被?嘧啶-5-甲醛
|
147117-37-4
|
|
Tert-Butyl 6-[(1E)-2-[4-(4-fluoro-
phenyl)-6-(1-methyl-
ethyl)-2-[methyl-
(methylsulfonyl)-
amino]-5-pyrimidinyl]-
ethenyl]-2,2-dimethyl-
1,3-dioxane-4-
acetate
|
6-[(1E)-2-[4-(4-氟苯基)-6-異丙基-2-[甲基(甲磺酰)氨基]-5-嘧啶]乙烯基]-2,2-二甲基-1,3-二氧六環(huán)-4-乙酸叔丁酯
|
289042-12-2
|
|
Pranoprofen impurity 3
|
Pranoprofen
related substance
普拉洛芬相關(guān)物質(zhì)
|
|
|
Imp-2
|
Elaglolix related substance
噁拉戈利相關(guān)物質(zhì)
|
15386-73-9
|
|
Imp-3
|
Elaglolix related substance
噁拉戈利相關(guān)物質(zhì)
|
|
|
DHPCOOMe
|
Lecardipine HCl
related substance
樂卡地平相關(guān)物質(zhì)
|
|
|
Dabigatran P-1
|
達比加群酯P-1
|
211915-06-9
|
|
Elagolix intermediate 2
|
噁拉戈利中間體 2
|
830346-47-9
|
|
Elagolix intermediate 3
|
噁拉戈利中間體 3
|
1150560-54-5
|
|
Elagolix intermediate 4
|
噁拉戈利中間體 4
|
830346-48-0
|
|
Elagolix intermediate 5
|
噁拉戈利中間體 5
|
1150560-59-0
|
|
Elagolix intermediate 6
|
噁拉戈利中間體 6
|
830346-50-4
|
|
Ticagrelor
|
替格瑞洛
|
274693-27-5
|
|
Sitagliptin Phosphate Monohydrate
|
磷酸西格列汀一水合物
|
654671-77-9
|
|
Tenofovir Alafenamide Hemifumarate
|
泰諾福韋艾拉酚胺半富馬酸鹽
|
1392275-56-7
|
|
Sitagliptin free base
|
西格列汀游離堿
|
486460-32-6
|
|
Silodosin impurity 3
|
西洛多辛雜質(zhì) 3
|
239463-85-5
|
|
Ivy Leaf Extract
|
常春藤提取物
|
|
|
TPPU(CS-2462)
|
CS-2462
|
1222780-33-7
|
|
Toremifene
|
托瑞米芬
|
89778-26-7
|
|
chlorantraniliprole impurity
|
氯蟲苯甲酰胺雜質(zhì)
|
438450-43-2
|
|
ZSTK474
|
2-(2-二氟甲基苯并咪唑-1-基)-4,6-二嗎啉基-1,3,5-三嗪
|
475110-96-4
|
|
CDP-Star
|
CDP-STAR化學(xué)發(fā)光底物
|
160081-62-9
|
|
Sodium Picosulfate impurity B
|
匹可硫酸鈉雜質(zhì)B
|
603-41-8
|
|
Tenofovir Disoproxil
|
泰諾福韋酯游離堿
|
201341-05-1
|
|
5-Pyrimidinecarboxamide, 4-[[2-(hydroxymethyl)phenyl]amino]-2-[(1,2,3,4-tetrahydro-6-methoxy-2-methyl-7-isoquinolinyl)amino]-
|
HPK1對照
|
2739844-28-9
|
|
Artemisia Extract
|
艾葉提取物
|
|
|
Raloxifene parent nucleus
|
雷洛昔芬主環(huán)
|
63675-74-1
|
|
BI-6727
|
N-[反式-4-[4-(環(huán)丙基甲基)-1-哌嗪基]環(huán)己基]-4-[[(7R)-7-乙基-5,6,7,8-四氫-5-甲基-8-異丙基-6-氧代-2-蝶啶基]氨基]-3-甲氧基苯甲酰胺
|
755038-65-4
|
|
Sphingosine
|
鞘氨醇
|
123-78-4
|
|
CNX1351
|
CNX1351
|
1276105-89-5
|
|
PDP-LA
|
化合物 T28353
|
861891-72-7
|
|
Dexecadotril
|
八氫氨吖啶
|
13415-07-1
|
|
Ozagrel cis isomer impurity-1
|
奧扎格雷雜質(zhì)1（順式異構(gòu)體）
|
143945-86-2
|
|
SN32976
|
SN-32976
|
1246202-11-8
|
|
Pranoprofen impurity C
|
普拉洛芬雜質(zhì)C
|
143436-36-6
|
|
Radezolid
|
雷德唑來
|
869884-78-6
|
|
Roxatidine Acetate HCl
|
羅沙替丁醋酸酯鹽酸鹽
|
93793-83-0
|
|
Diclofenac Epolamine impurity 3
|
雙氯芬酸依泊胺雜質(zhì) 3
|
27204-57-5
|
|
Bisacodyl
|
比沙可定
|
603-50-9
|
|
Dried Coptidis Rhizoma Extract
|
黃連提取物
|
2086-83-1
|
|
Tegoprazan side chain
|
特戈拉贊側(cè)鏈
|
1270294-05-7
|
|
Indobufen impurity 1
|
吲哚布芬雜質(zhì) 1
|
76553-18-9
|
|
Ozagrel impurity-7
|
奧扎格雷雜質(zhì)7
|
883903-91-1
|
|
Trityl Olmesartan acid ethyl ester
|
三苯甲基奧美沙坦酸乙酯
|
189400-21-3
|
|
Rosuvastatin glyceride
|
羅素伐他汀甘油酯
|
|
|
BI-2536
|
BI 2536
|
755038-02-9
|
|
Lesinurad
|
雷西納德
|
878672-00-5
|
|
AZ-20
|
AZ20
|
1233339-22-4
|
|
Silodosin impurity 1
|
西洛多辛雜質(zhì) 1
|
2182279-45-2
|
|
Diclofenac Epolamine
|
雙氯芬酸依泊胺
|
119623-66-4
|
|
GDC-0941
|
GDC-0941
|
957054-30-7
|
|
Silodosin
|
西洛多辛
|
160970-54-7
|
|
Elagolix intermediate 1
|
噁拉戈利中間體 1
|
830346-46-8
|
|
Crisaborole
|
克立硼羅
|
906673-24-3
|
|
BIBR1150
|
BIBR1150,達比加群酯 雜質(zhì)對照品
|
1408238-36-7
|
|
2,4'-(2-Pyridylmethylene)diphenol Bis(hydrogen sulfate) Disodium Salt
|
匹可硫酸鈉雜質(zhì)C
|
|
|
Diclofenac Epolamine impurity 1
|
雙氯芬酸依泊胺雜質(zhì) 1
|
15362-40-0
|
|
EC5026
|
EC-5026
|
1809885-32-2
|
|
BIIB068
|
BIIB068
|
1798787-27-5
|
|
Eupatilin
|
異澤蘭黃素
|
22368-21-4
|
|
Jaceosidin
|
棕矢車菊素
|
18085-97-7
|
|
Elagolix
|
噁拉戈利
|
834153-87-6
|
|
BIBR1087
|
BIBR1087,達比加群酯 雜質(zhì)對照品
|
212321-78-3
|
|
BIBR1154
|
BIBR1154,達比加群酯 雜質(zhì)對照品
|
1408238-40-3
|
|
Choline Glycerophosphate (GPC)
|
甘磷酸膽堿
|
28319-77-9
|
|
Rebamipide
|
瑞巴派特
|
90098-04-7
|
|
Raloxifene side chain
|
雷洛昔芬側(cè)鏈
|
84449-80-9
|
|
Landiolol Hydrochloride
|
鹽酸蘭地洛爾
|
144481-98-1
|
|
d-Toremifene
|
氘代托瑞米芬
|
|
|
Indobufen
|
吲哚布芬
|
63610-08-2
|
|
Roxatidine impurity 2
|
羅沙替丁雜質(zhì) 2
|
110925-92-3
|
|
Green tea extract
|
綠茶提取物
|
|
|
Raloxifene HCl
|
雷洛昔芬鹽酸鹽
|
82640-04-8
|
|
Butanoic acid, 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3,6-dihydro-4-methyl-2,6-dioxo-3-[[2-(trifluoromethyl-6-fluoro)phenyl]methyl]-1(2H)-pyrimidinyl]-1-phenylethyl]amino]-
|
噁拉戈利雜質(zhì) 2
|
2316733-82-9
|
|
Rebamipide amino HCl salt
|
瑞巴派特胺基鹽酸鹽
|
132210-24-3
|
|
BIBR951
|
BIBR952,達比加群酯 雜質(zhì)對照品
|
429658-95-7
|
|
N-Ts Tegoprazan parent nucleus
|
942195-86-0
|
|
Tenofovir Alafenamide acid
|
泰諾福韋艾拉酚酸
|
379270-35-6
|
|
Ilaprazole intermediate P-1
|
艾普拉唑中間體P-1
|
172152-35-1
|
|
Clotrimazole
|
克霉唑
|
23593-75-1
|
|
UC-1728
|
UC-1728
|
948304-40-3
|
|
Sodium Picosulfate
|
匹可硫酸鈉
|
10040-45-6
|
|
Tenofovir Disoproxil Fumarate
|
泰諾福韋酯富馬酸鹽
|
202138-50-9
|
|
Peramivir
|
帕拉米韋
|
229614-55-5
|
|
PMPA
|
泰諾福韋
|
147127-20-6
|
|
Silodosin side chain
|
西洛多辛側(cè)鏈
|
160969-03-9
|
|
Ozagrel methylester
|
奧扎格雷酯
|
866157-50-8
|
|
Olmesartan Medoxomil
|
奧美沙坦酯
|
144689-63-4
|
|
Trityl Olmesartan acid
|
三苯甲基奧美沙坦酸
|
761404-85-7
|
|
Baricitinib
|
巴瑞克替尼
|
1187594-09-7
|
|
GSK 2256294
|
SEH抑制劑(GSK2256294A)
|
1142090-23-0
|
|
Tegoprazan
|
特戈拉贊
|
942195-55-3
|
|
Deoxycholic acid
|
去氧膽酸
|
83-44-3
|
|
Ozagrel impurity-C
|
奧扎格雷雜質(zhì)C
|
|
|
Diclofenac Epolamine impurity 5
|
雙氯芬酸依泊胺雜質(zhì) 5
|
69002-84-2
|
|
Trityl Olmesartan Medoxomil
|
三苯甲基奧美沙坦酯
|
144690-92-6
|
|
Fexuprazan
|
非蘇拉贊
|
1902954-60-2
|
|
Indobufen impurity 4
|
吲哚布芬雜質(zhì) 4
|
94232-67-4
|
|
Pranoprofen
|
普拉洛芬
|
52549-17-4
|
|
Dabigatran Etexilate Mesylate pellet
|
甲磺酸達比加群酯微丸
|
872728-81-9
|
|
Mono-POC-PMPA
|
泰諾福韋單酯
|
211364-69-1
|
|
Tenofovir Alafenamide free base
|
泰諾福韋艾拉酚胺游離堿
|
379270-37-8
|
|
t-AUCB
|
反式AUCB
|
885012-33-9
|
|
Octahydroaminoacridine
|
琥珀八氫氨吖啶
|
866245-79-6
|
|
1-(5-(1H-pyrrol-1-yl)-1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid
|
艾普拉唑雜質(zhì) 2
|
|